Dysfunctional CD4 T cells in an oncovirus-specific TCR-transgenic in vivo model

Felicia S Spitzer, Marcel G M Camps, Cedrik M Britten, Sandra Vloemans, Hester J T van Zeeburg, Cornelis J M Melief, Tsolere Arakelian, Ferry Ossendorp · 2025

Read Dysfunctional CD4 T cells in an oncovirus-specific TCR-transgenic in vivo model by Felicia S Spitzer, Marcel G M Camps, Cedrik M Britten, Sandra Vloemans, Hester J T van Zeeburg, Cornelis J M Melief, Tsolere Arakelian, Ferry Ossendorp (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12827954.txt.

Description

Felicia Spitzer and co-authors present a new mouse model of dysfunctional CD4 T cells, in a 2025 paper. T cell exhaustion is implicated in cancer and chronic infections alike. Their model, named MolT-II, gives the T cells a built-in receptor tuned to a peptide from a Moloney virus coat protein. The cells can thus be tracked and triggered with precision in a living animal.

The model's CD4 cells prove dysfunctional: weak effector function, poor growth, and high levels of braking receptors on their surface. The likely cause is chronic exposure to a self-antigen. A peptide vaccine combined with checkpoint blockade restores their function in the animal, with better tumor control. The strain offers a reversible test bed for studying CD4 regulation.

Catalog record

CREATORFelicia S Spitzer, Marcel G M Camps, Cedrik M Britten, Sandra Vloemans, Hester J T van Zeeburg, Cornelis J M Melief, Tsolere Arakelian, Ferry Ossendorp
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE56 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12827954

Browse the full library · About the Tower of Babel